Versatile strategy for controlling the specificity and activity of engineered T cells. [electronic resource]
Producer: 20160613Description: E450-8 p. digitalISSN:- 1091-6490
- Animals
- Antigens, CD19 -- immunology
- Antigens, Neoplasm -- immunology
- Azides
- B-Lymphocytes -- immunology
- Cell Line, Tumor
- Cytotoxicity, Immunologic
- Female
- Fluorescein-5-isothiocyanate
- Genetic Vectors
- Humans
- Immunotherapy, Adoptive -- adverse effects
- Lentivirus -- genetics
- Leukemia, B-Cell -- therapy
- Lymphocyte Activation
- Lymphopenia -- etiology
- Mice
- Mice, Inbred C57BL
- Mice, Inbred NOD
- Mice, SCID
- Models, Molecular
- Phenylalanine -- analogs & derivatives
- Protein Conformation
- Protein Engineering -- methods
- Receptors, Antigen, T-Cell -- genetics
- Recombinant Fusion Proteins -- immunology
- Sialic Acid Binding Ig-like Lectin 2 -- immunology
- Single-Chain Antibodies -- genetics
- T-Cell Antigen Receptor Specificity
- T-Lymphocytes -- immunology
- Transduction, Genetic
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.